Valuation: LeMaitre Vascular, Inc.

Market Cap 1.81B 1.62B 1.51B 1.37B 2.59B 175B 2.61B 18.17B 7.1B 89.23B 6.81B 6.66B 287B P/E 2026 *
27.6x
P/E 2027 * 25x
Enterprise Value 1.57B 1.41B 1.31B 1.19B 2.24B 152B 2.26B 15.76B 6.16B 77.4B 5.91B 5.78B 249B EV / Sales 2026 *
5.69x
EV / Sales 2027 * 5x
Free-Float
87.26%
Yield 2026 *
1.26%
Yield 2027 * 1.41%
1 day+1.44%
1 week-0.71%
Current month-3.45%
1 month+5.26%
3 months-23.91%
6 months-27.08%
1 week 69
Extreme 69
71.5
1 month 66
Extreme 66
72.5
Current year 66
Extreme 66
99
1 year 66
Extreme 66
99
3 years 42
Extreme 42
102
5 years 35.4
Extreme 35.4
102
10 years 19.1
Extreme 19.1
102
Manager TitleAgeSince
Chief Executive Officer 61 1992-05-31
Director of Finance/CFO 51 2025-03-09
Director of Finance/CFO 62 1999-12-31
Director TitleAgeSince
Director/Board Member 68 2002-12-31
Chairman 61 2003-12-31
Director/Board Member 61 2016-10-23
Change 5-day change 1-year change 3-year change Capi.($)
+1.44%-0.71% - - 1.81B
+0.83%-1.92%+22.79%+32.80% 245B
+1.34%-1.38%+4.66%+0.58% 154B
+2.41%+1.94%-5.99%+40.19% 146B
-1.45%-4.74%-56.64%-20.22% 60.26B
-0.81%-0.63%+11.81%+16.39% 49.44B
-0.14%-1.87%+22.03%+52.83% 47.67B
+1.29%+1.55%-20.54%-18.72% 48.04B
-0.35%-1.03%-7.75%+34.78% 45.74B
-0.10%-0.77%+36.95%+63.05% 42.84B
Average +0.28%-1.73%+0.81%+22.41% 93.2B
Weighted average by Cap. +0.71%-2.10%+4.63%+23.25%

Financials

2026 *2027 *
Net sales 277M 247M 231M 209M 394M 26.75B 397M 2.77B 1.08B 13.6B 1.04B 1.02B 43.74B 303M 271M 253M 229M 432M 29.3B 435M 3.03B 1.19B 14.9B 1.14B 1.11B 47.91B
Net income 66.71M 59.61M 55.61M 50.51M 95.14M 6.45B 95.85M 668M 261M 3.28B 250M 245M 10.55B 74.29M 66.38M 61.93M 56.25M 106M 7.19B 107M 744M 291M 3.65B 279M 273M 11.75B
Net Debt -240M -215M -200M -182M -343M -23.26B -346M -2.41B -941M -11.83B -903M -883M -38.04B -300M -268M -250M -227M -428M -29.06B -432M -3.01B -1.18B -14.78B -1.13B -1.1B -47.51B
Projected Income Statement - Annual - LeMaitre Vascular, Inc.
Logo LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. It develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which are used in open vascular surgery and dialysis access. It offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold globally in the United States, Europe, Canada and Asia Pacific.
Employees
651
Date Price Change
26-10-08 €70.00 +0.72%
26-10-07 €69.50 +0.72%
26-10-06 €69.00 -1.43%
26-10-05 €70.00 +1.45%
26-10-02 €69.00 -2.13%
Trader
Investor
Global
Quality
ESG MSCI
CCC
Ratings Surperformance© - LeMaitre Vascular, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
79.31USD
Average target price
107.00USD
Spread / Average Target
+34.91%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LeMaitre Vascular, Inc.